Aclasta Lavi 5mg Inj 100ml
Information About Aclasta Lavi 5mg Inj 100ml
About Aclasta Lavi 5mg Inj 100ml
Medicine Brand ACLASTA LAVI 5MG INJ 100ML is manufactured by NOVARTIS INDIA LIMITED SANDOZ and mainly contents the generic drug Zoledronic Acid.
Pakaging
1
Active Ingredients For Aclasta Lavi 5mg Inj 100ml
Zoledronic Acid 100ML
Diseases List For Which Aclasta Lavi 5mg Inj 100ml Is Prescribed
This Drug Is Prescribed For Hypercalcemia of malignancy Multiple myeloma Bone metastases from solid tumors Pagets disease Osteoporosis in postmenopausal women
Other Significations For Aclasta Lavi 5mg Inj 100ml
This Medication Zoledronic acid is an injectable drug belonging to a class of drugs called bisphosphonates that strengthen bone and are used primarily to treat osteoporosis Zoledronic acid also is the active drug in Zometa which is used for treating cancer The bisphosphonate class includes etidronate Didronel pamidronate Aredia risedronate Actonel ibandronate Boniva and tiludronate Skelid Bone is in a constant state of remodeling New bone is laid down by cells called osteoblasts while old bone is removed by cells called osteoclasts Bisphosphonates strengthen bone by inhibiting bone removal resorption by osteoclasts After menopause there is an increased rate of bone loss leading to osteoporosis Bisphosphonates increase bone density and decrease bone fractures The FDA approved Reclast in August 2007
Precautions To Be Taken Before Aclasta Lavi 5mg Inj 100ml
Combining Zoledronic Acid With Aminoglycoside Antibiotics Such As Gentamycin Or Loop Diuretics Such As Furosemide Lasix Or Bumetanide Bumex May Lead To Reduced Calcium In Blood Zoledronic Acid Should Be Used With Caution In Patients Who Are Taking Drugs That Affect Kidney Function Because Zoledronic Acid Has Been Associated With Reduced Kidney Function Since Reclast Contains The Same Active Ingredient As Zometa Zoledronic Acid Patients Treated With Zometa Should Not Receive Reclast
Major Conditions And Care
Pregnancy And Aclasta Lavi 5mg Inj 100ml
Can We Take Aclasta Lavi 5mg Inj 100ml During Pregnancy?
Pregnancy Class : D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks
Lactation And Aclasta Lavi 5mg Inj 100ml
Can We Use Aclasta Lavi 5mg Inj 100ml During Lactation
Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective
Side Effects Of Aclasta Lavi 5mg Inj 100ml
Nausea stomach upset skin rash acute toxicity